InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,954.50
(
1.59%
)
US TECH 100
20,332.80
(
1.61%
)
Dow Jones
43,840.91
(
1.39%
)
Brent Oil
73.05
(
0.00%
)
Bitcoin
86,364.64
(
0.37%
)
Post# of 112
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jondoeuk

Send PM Follow Ignore
Followers 34
Posts 3015
Boards Moderated 1
Alias Born 10/24/2015

jondoeuk

Re: None

Thursday, 08/05/2021 1:04:04 PM

Thursday, August 05, 2021 1:04:04 PM

Post# of 112
At ESMO, Dr. Catenacci will give an oral presentation entitled: Clinical outcomes and immune responses in a Phase 1/2 study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GRTSQ News
More GRTSQ News
InvestorsHub NewsWire

VAYK Proposes 100 million Buyback through Private Repurchases • VAYK • Feb 28, 2025 9:00 AM

ConnectM Eliminates an Additional $1.9 Million of Debt • CNTM • Feb 27, 2025 4:01 PM

Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc. • CAFI • Feb 27, 2025 9:00 AM

VPR Brands Secures Settlement Agreement With POP Vapor, Reinforcing Commitment to Intellectual Property Protection • VPRB • Feb 27, 2025 8:49 AM

Wytec Begins Sales of Its Multi-Government AI Threat Detection Sensor Technology • WYTC • Feb 27, 2025 7:05 AM

VAYK Issues Clerical Correction to Feb 18 News Regarding Shareholder Premium • VAYK • Feb 26, 2025 10:32 AM

Start posting your company's news
Only $200 per official company press release!